SCA
CRL icon

Secor Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Secor Capital Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,257
Closed -$269K – 548
2016
Q2 		$269K Buy
+3,257
New +$268K 0.03% 493

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Secor Capital Advisors's CRL Position: Q3 2016 in Review

Secor Capital Advisors sold out of Charles River Laboratories (CRL) in Q3 2016, closing a stake of 3,257 shares — an estimated $269K sold.

Secor Capital Advisors first reported a position in CRL in Q2 2016 and held it in 1 quarter. The position peaked at $269K in Q2 2016. 284 funds tracked by Wall St. Rank hold CRL as of Q3 2016.

  • Secor Capital Advisors reported no remaining Charles River Laboratories position as of Q3 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 3,257 Charles River Laboratories shares in Q3 2016, an estimated $269K.
  • Secor Capital Advisors first reported a position in Charles River Laboratories in Q2 2016 and held it in 1 quarter.
  • Secor Capital Advisors's Charles River Laboratories position peaked at $269K in Q2 2016.
  • 284 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2016.

Based on Secor Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.